The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets

Overview of attention for article published in Frontiers in oncology, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 12,122 followers.

We've detected a paper from Frontiers in Oncology that cites a retracted paper post-retraction. Citing paper: https://t.co/S0rCk4TfYe Retracted paper: https://t.co/LNfb1uiDyt

10 May 2023

Reply Repost Favourite

CXCL12アゴニストと免疫チェックポイント阻害薬などの併用が膵癌の免疫応答の改善->予後の改善につながる可能性 https://t.co/9ixRKqObr2

10 Apr 2023

Reply Repost Favourite

New research: The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets: Introduction Chemokines are small, secreted peptides involved in the mediation of the immune cell recruitment. Chemokines have been implicated in… https://t.

02 Apr 2023

Reply Repost Favourite

RT @Dr_Ivanoncologo: The CXCL12 axis may predict disease progression and the timing of the development of potential new #biomarkers and the…

25 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.